1 month on tirzepatide SHOCKING 2 Results My 1-Month Update on Compounded
Description
Neurology 48 (6), 16381642
Semaglutide achieved a 26% MACE reduction (HR 0.74, 95% CI 0.580.95), mainly through a 39% decrease in non-fatal stroke [37]
I miss Phyllis terribly, but Laura is wonderful
Talk to your doctor for individual recommendations on form and dosing
When prescribing a weight loss medication, its important to walk the patient through any future possibility of pregnancy, along with side effects
